콘텐츠로 건너뛰기
Edisbiothec Logo
  • COMPANY
    • About Us
    • Leadership
    • History
    • Partnership
    • Contact Us
  • R&D
    • Basic concept /Core technology
    • Tumor microenvironment
    • Antibody-based cancer therapeutics
    • Biomarker-Based Precision Medicine
    • Molecular imaging
  • PIPELINE
    • Overview
    • ED1
    • ED2
  • PR
    • Notice
    • Press Release
    • Resource
  • ENG
    • KOR
  • COMPANY
    • About Us
    • Leadership
    • History
    • Partnership
    • Contact Us
  • R&D
    • Basic concept /Core technology
    • Tumor microenvironment
    • Antibody-based cancer therapeutics
    • Biomarker-Based Precision Medicine
    • Molecular imaging
  • PIPELINE
    • Overview
    • ED1
    • ED2
  • PR
    • Notice
    • Press Release
    • Resource

Notice & PR

  • Notice
  • Press Release
  • Resource
  • 6

    Professor Seung-Jae Myung "Bioimaging techniques are increasingly utilized, particularly in efficacy assessments for drug devel

    2017.05.26

  • 5

    Detecting hidden cancers within the body using infrared rays.

    2017.03.05

  • 4

    A collaborative Research Team of Asan Medical Center and KAIST has first revealed that Excessive Interaction of 'Colon Cell Reg

    2017.01.16

  • 3

    Interview with Professor Myung Seung-Jae: 'Continuing the Challenge and Response in the Conquest of Disease.

    2016.08.08

  • 2

    A collaborative research team composed of Asan Medical Center, POSTECH (Pohang University of Science and Technology), and Gwang

    2016.06.20

  • 1

    Selected as a participating enterprise for development of 'Smart convergent endoscopy' (The Ministry of Trade, Industry and Ene

    2016.05.25

  • First
  • «
  • 1
  • 2

R&D

Core technologies and R&D background

PIPELINE

Biomarker-driven anti-cancer therapy development

To top

EdisBiotech

Address
Olympic-ro 43-gil, Songpa-gu, Seoul, Korea (11th floor, AMC Convergence Center)
Tel
02-3010-8589
EdisBiotech

COPYRIGHT 2024. EdisBiotech ALL RIGHTS RESERVED.

Contact Us
닫기